A systematic approach for early identification of BP effects during development of new drugs.
Michael A. Weber, MD
Advertisement
Articles by Michael A. Weber, MD
More attention is being paid to blood pressure effects in new chemical entities under development for non-hypertension indications.
Advertisement
Latest Updated Articles
A Proposed Approach for Blood Pressure Evaluation During Early Phase Human Trials of New DrugsPublished: July 22nd 2014 | Updated:
- Blood Pressure Evaluation During Early Phase Trials
Published: October 1st 2014 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
2025 SCRS Global Site Solutions Summit: How Technology Vendors Can Reduce Site Burden and Improve Trial Execution
3
AI in Action: Breaking Down Clinical Trial Bottlenecks
4
Focusing on Site Needs and Challenges: Quick Tips for Sponsors/CROs
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
